Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cerner to buy assets of Siemens' health business for $1.3 billion
Yahoo/Reuters
Tuesday, August 5, 2014 - 4:38pm
tags:
Cerner, Siemens, M&A
Zoetis plans vaccine against killer U.S. pig virus
Yahoo/Reuters
Tuesday, August 5, 2014 - 2:15pm
tags:
Zoetis, vaccines, animal health
Roche persuades U.S. judge to toss $2M Accutane verdict
Fierce Pharma
Tuesday, August 5, 2014 - 2:13pm
tags:
Roche, Accutane
FDA Clears Path for Botox Imitators
RAPS.org
Tuesday, August 5, 2014 - 2:01pm
tags:
Allergan, Botox, FDA
Hopes build for new Novartis heart failure drug
Reuters
Tuesday, August 5, 2014 - 1:52pm
tags:
heart failure, Novartis, LCZ696
Glitch Prompts Temporary Shutdown of Pharma Payment Verification System
ProPublica
Tuesday, August 5, 2014 - 1:46pm
tags:
physicians, payment verification systems, Medicaid, Medicare
Is Medicare wasting $220M a year on Questcor's controversial Acthar?
Fierce Pharma
Tuesday, August 5, 2014 - 1:43pm
tags:
Acthar, Questcor, Medicare
Congress moves to punish Medtronic and other 'corporate deserters'
Mass Device
Tuesday, August 5, 2014 - 1:42pm
tags:
tax inversions, medronic, devices, device tax
Actavis Beats on Q2 Earnings & Revs, Provides 2015 Outlook
Yahoo/Zacks.com
Tuesday, August 5, 2014 - 1:22pm
tags:
earnings, Actavis
Note to Big Pharma: Discounts work. GSK price cuts score Advair a payer boost
Fierce Pharma
Tuesday, August 5, 2014 - 11:40am
tags:
GSK, Advair, drug discounts
Allergan Being ’Obstructive’ in Deal Defense, Firm Says
Bloomberg
Tuesday, August 5, 2014 - 11:32am
tags:
Allergan, Valeant Pharmaceuticals, M&A
The Positives and Negatives of Pfizer's $635 purchase of Baxter's Vaccines
Yahoo/Benzinga
Tuesday, August 5, 2014 - 11:25am
tags:
Pfizer, vaccines, M&A, Baxter International
Have Faster FDA Drug Approvals Caused More Safety Problems?
WSJ Online
Tuesday, August 5, 2014 - 10:24am
tags:
FDA, drug approvals
Allergan Comments on Valeant’s Second Quarter 2014 Earnings Results
Yahoo
Tuesday, August 5, 2014 - 10:11am
tags:
Allergan, Valeant Pharmaceuticals, earnings, M&A
Regeneron sales top forecast as Eylea picks up steam
Yahoo/Reuters
Tuesday, August 5, 2014 - 10:01am
tags:
earnings, Eylea, Regeneron
Pfizer Megadeal Still in Sight After Astra: Real M&A
Bloomberg
Tuesday, August 5, 2014 - 9:06am
tags:
Pfizer, AstraZeneca, M&A, GSK, Actavis
Juno Therapeutics Has Raised $300 Million In Just 12 Months
Forbes
Tuesday, August 5, 2014 - 9:04am
tags:
Juno Therapeutics, CARTs
Ebola Drug Provided for Two Americans by Nine-Employee Company
Yahoo/Bloomberg
Tuesday, August 5, 2014 - 8:47am
tags:
ebola virus, Mapp Biopharmaceutical, ZMapp
Sarepta Ready to Provide Ebola Drug if Needed
Barron's
Tuesday, August 5, 2014 - 8:05am
tags:
Sarepta Therapeutics, ebola virus
Novo Nordisk Leapfrogs Glaxo as U.K. Drug Giant Declines
Bloomberg
Tuesday, August 5, 2014 - 8:01am
tags:
Novo Nordisk, GSK, insulin, diabetes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.